Innovative Vaccine Bursaplex

Infectious bursal disease (Gumboro disease) severely impacts the immune system of young poultry, making the flock vulnerable to secondary infections and reducing the effectiveness of other vaccines. To ensure reliable protection from the first days of life, Zoetis developed the innovative Bursaplex vaccine. Its unique formula combines the virus with antibodies, ensuring complete safety and allowing the formation of active immunity even in the presence of maternal antibodies in chicks.

The main advantage of Bursaplex for large incubators and poultry farms is that a single dose provides lifelong protection for the flock. A robust immune response develops within 7 days after administration. The vaccine is officially approved for use via the advanced in ovo method (injection directly into the embryo on day 18–19 of incubation) and for classic subcutaneous injection in day-old chicks. This guarantees 100% dosing accuracy, minimizes stress for the birds, and is ideal for automated production processes.

Implementing Bursaplex in your farm’s veterinary protection protocol ensures healthy and viable young stock. Reliable prevention of immunosuppression improves feed efficiency, reduces mortality, and enhances overall productivity. Choosing Bursaplex is an investment in biosecurity and stable profitability for every production cycle.